miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.
about
MicroRNAs as lung cancer biomarkersp40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastasesMicroRNAs As Biomarkers For Clinical Features Of Lung CancerUse of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes.A cross-platform comparison of affymetrix and Agilent microarrays reveals discordant miRNA expression in lung tumors of c-Raf transgenic miceAdvances in fine needle aspiration cytology for the diagnosis of pulmonary carcinoma.Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.Statistical analysis of a Bayesian classifier based on the expression of miRNAs.Applications of MicroRNAs in the Diagnosis and Prognosis of Lung CancerMolecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer.miRNAs in lung cancer: large roles for small players.Fine needle aspiration of non-small cell lung cancer: current state and future perspective.Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis.Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice.MicroRNAs: a new key in lung cancer.microRNA and Lung Cancer.A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing.Utility of p40 in the Differential Diagnosis of Small Round Blue Cell Tumors of the Sinonasal TractA prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma.Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies.microRNAs Make the Call in Cancer Personalized Medicine.Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.Utility and pattern of positivity of p40 in the diagnosis of squamous cell carcinoma of the lung by cytology: the first study on fine needle aspiration smears.MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer.MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.
P2860
Q34031213-07AB3E00-56F0-4E6D-A583-0955B22683F7Q34067972-80D4DFBE-5FE3-4482-8D4D-BC6E26732A01Q34143922-6AE80FE7-6232-40E8-BA0E-54D8CECD589BQ34158964-EB4F1489-824A-4303-BAE7-0255767B02B3Q35038162-B76679D0-2BB7-4DFB-9FCF-874C83AE5278Q35050372-C3D3A4FB-01F2-49CC-8F55-5BD47A255ABCQ35110001-9D15627E-CC64-42A2-AF03-F27AC18D5BBCQ35190111-7D2A1C27-4C45-4583-8C69-4C3D22E253DDQ35561695-1D683DF5-B85E-4216-9F75-1A7BCA746CEEQ35764274-50A825E8-3869-4B63-9703-275949F007B4Q35970795-CFDD5775-8FA2-413E-88AC-834261BFB8DDQ37653893-FD157C65-AD23-42FF-859E-52D92A6C695CQ37902246-79189F4E-B013-49F9-9380-5514A5491055Q37932539-9A7E5B63-653F-494D-BF35-2D4B970A5B4FQ38026995-2ED22CAB-7FA8-4D38-AC66-2622FE8E2A82Q38107464-2EC27EE4-EF19-450C-B021-3ED5470BB390Q38112386-FB925E3E-FB22-4721-97DB-3BF7710C99E5Q38241121-F67A2D4F-6BAA-42AA-A191-5E1210D279AFQ38667020-8131C15E-6875-4F45-9054-6D59406F8CBBQ38688031-1B462BD3-0D9F-43AF-BD8F-E7AD81D01A16Q38999884-D0684B56-34FF-46A3-9830-51A0DBDB5C09Q39663980-31BC5363-5D32-4C38-ACB8-E9556FBB9F35Q40503461-95E06CCC-09BB-4553-AB07-CCE7FBA68627Q40603527-0FF299C4-6C09-4083-8193-AB1EFE332C42Q42156325-101E8DEE-7F1F-4FE0-9DC8-B13581634BAAQ44280426-19410B38-8427-44CF-824E-9E9B09D45F69Q44988491-2B8108ED-C794-4140-BC4C-CF242BBB0909Q47141611-73D814BF-9C8A-42BB-BB11-94A0B7C8E44BQ50135786-1A0DC746-6587-4C55-B69C-220F52EFCCFBQ51563657-E1E4C276-0BF5-47AB-8215-B626698519DFQ54308682-DBDBE987-86A3-481B-995C-9B3F55F4F235
P2860
miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
miR-205 Expression levels in n ...... from squamous cell carcinomas.
@en
miR-205 Expression levels in n ...... from squamous cell carcinomas.
@nl
type
label
miR-205 Expression levels in n ...... from squamous cell carcinomas.
@en
miR-205 Expression levels in n ...... from squamous cell carcinomas.
@nl
prefLabel
miR-205 Expression levels in n ...... from squamous cell carcinomas.
@en
miR-205 Expression levels in n ...... from squamous cell carcinomas.
@nl
P2093
P50
P1476
miR-205 Expression levels in n ...... from squamous cell carcinomas.
@en
P2093
Alberto Cucino
Chiara Cantaloni
Emma Bragantini
Giuseppe Pelosi
Lucia Veronica Cuorvo
Massimo Silvestri
Mattia Barbareschi
Mauro Papotti
Paolo Dalla Palma
Salvatore Girlando
P304
P356
10.1097/PAS.0B013E3182068171
P407
P577
2011-02-01T00:00:00Z